We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Ultrasound Device Noninvasively Stimulates Deep Brain Regions for Treating Chronic Pain

By MedImaging International staff writers
Posted on 30 Aug 2024
Print article
Image: The Diadem device is designed to treat chronic pain and depression (Photo courtesy of The University of Utah)
Image: The Diadem device is designed to treat chronic pain and depression (Photo courtesy of The University of Utah)

Pain serves as a vital biological warning, but in many conditions, it becomes distorted. Chronic pain sufferers often deal with persistent, erroneous pain signals originating from the brain, signaling non-existent injuries such as healed wounds or missing limbs. These individuals are in constant search for new therapies. Now, a new device using focused ultrasonic waves to noninvasively target and modulate pain circuits offers a promising breakthrough.

Diadem, the new biomedical device developed by researchers at the University of Utah’s John and Marcia Price College of Engineering (Salt Lake City, UT, USA) and Spencer Fox Eccles School of Medicine (Salt Lake City, UT, USA), employs ultrasound technology to stimulate deep brain areas, aiming to disrupt the faulty signals responsible for chronic pain. Unlike other neuromodulation techniques that utilize electrical or magnetic fields, Diadem can specifically target a region known as the anterior cingulate cortex, which traditional methods cannot accurately reach. Prior to treatment, patients undergo a functional MRI to map this target area, allowing researchers to precisely adjust the ultrasound emitters to account for anatomical variances like skull density and brain structure.

The device's effectiveness was highlighted in a recent clinical trial, the results of which appeared in the journal Pain. The study involved 20 chronic pain sufferers who underwent two 40-minute sessions with the Diadem device, receiving either actual or placebo ultrasound stimulation. The outcomes assessed a day and a week post-treatment showed that 60% of those in the real treatment group reported significant pain reduction at both time points. Following these encouraging results, the researchers are moving towards a Phase 3 clinical trial, which is the final stage before seeking FDA approval for public use of Diadem.

“The rapid onset of the pain symptom improvements as well as their sustained nature are intriguing, and open doors for applying these noninvasive treatments to the many patients who are resistant to current treatments,” said Jan Kubanek, a professor in Price’s Department of Biomedical Engineering, who conducted the study.

Related Links:
John and Marcia Price College of Engineering
Spencer Fox Eccles School of Medicine

Silver Member
X-Ray QA Meter
T3 AD Pro
Ultra-Flat DR Detector
meX+1717SCC
New
Mammo 3D Performance Kits
Mammo 3D Performance Kits
X-ray Diagnostic System
FDX Visionary-A

Print article

Channels

Nuclear Medicine

view channel
Image: PSMA-PET/CT images of an 85-year-old patient with hormone-sensitive prostate cancer (Photo courtesy of Dr. Adrien Holzgreve)

Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients

Prostate-specific membrane antigen–positron emission tomography (PSMA-PET) imaging has become an essential tool in transforming the way prostate cancer is staged. Using small amounts of radioactive “tracers,”... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.